November 04, 2026

Proscia: Choosing the Right Digital Pathology Platform: 7 Criteria for a Better Experience with Your AI Applications

From the Proscia blog: Labs now expect their digital pathology platform to offer a broad range of AI applications from multiple vendors. But access alone isn’t enough. The platform also shapes how pathologists, scientists, and lab teams experience these...

recent articles

Indica Labs: Learn how the 510(k)-cleared HALO AP Dx platform can be used for comprehensive workflows in primary diagnostics Introducing HALO AP Dx: An Enterprise Pathology Platform for Primary Diagnosis Date: 13 June...

Indica Labs: HALO AP Dx brings digital primary diagnosis to anatomic pathology labs in the US. ALBUQUERQUE, NM / ACCESSWIRE / May 8, 2024 / Indica Labs, the leading provider of digital pathology solutions, announced today that it received...

From the Glencoe Software blog: Since the original release of the specification for the Next Generation File Format (NGFF) OME-Zarr, Glencoe Software has been dedicated to building implementations of these concepts. Now has come the time to...

From ArteraAI: Results identified 40% of BCR patients who benefited from therapy intensification vs. 60% of patients who did not The data revealed during the 2024 AUA Annual Meeting displays promise for a more personalized...

Deciphera Shareholders to Receive $25.60 per Share in Cash Deciphera’s Kinase Inhibitor Expertise and Established Commercialization Platform in Key Markets Will Reinforce ONO Pharmaceutical’s Pipeline and Accelerate Global...

PathAI: Transaction is part of wide-ranging collaboration to combine Quest's oncology expertise and scale with PathAI's AI and digital pathology innovations to speed diagnosis, improve quality and reduce costs  SECAUCUS, N.J. and BOSTON –...

OR

platinum partners

gold partners

Silver Partners

Media Partners